9 Reasons to Buy Pfizer in 2018 and 1 Big One Not To Post author:Sam Post published:December 21, 2017 Post category:BioPharma Pfizer may be the surprise strong-growth stock for next year. Source: BioSpace You Might Also Like <b>Ackman</b> Is Finally Done With Valeant, Takes $2.8 Billion Loss and Will Step Down From Board March 13, 2017 Calithera Biosciences Appoints To Board Of Directors September 21, 2017 Spark Therapeutics Further Expands Gene Therapy Expertise With Appointment Of As Chief Scientific Officer September 24, 2017
<b>Ackman</b> Is Finally Done With Valeant, Takes $2.8 Billion Loss and Will Step Down From Board March 13, 2017
Spark Therapeutics Further Expands Gene Therapy Expertise With Appointment Of As Chief Scientific Officer September 24, 2017
